Search results
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 hours agoPfizer stock jumped to its 50-day moving average in early May after the company beat first-quarter...
Pfizer Jumps On 'Massive' First-Quarter Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 23 minutes agoPfizer stock surged Wednesday after the pharma giant walloped analysts' first-quarter earnings...
BioNTech SE's (NASDAQ:BNTX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market...
Simply Wall St. via Yahoo Finance· 7 months agoWith its stock down 12% over the past month, it is easy to disregard BioNTech (NASDAQ:BNTX)....
Will Weakness in BioNTech SE's (NASDAQ:BNTX) Stock Prove Temporary Given Strong Fundamentals?
Simply Wall St. via Yahoo Finance· 2 months agoWith its stock down 7.5% over the past three months, it is easy to disregard BioNTech (NASDAQ:BNTX)....
Is BioNTech SE's (NASDAQ:BNTX) Latest Stock Performance A Reflection Of Its Financial Health?
Simply Wall St. via Yahoo Finance· 2 years agoMost readers would already be aware that BioNTech's (NASDAQ:BNTX) stock increased significantly by...
Is Weakness In BioNTech SE (NASDAQ:BNTX) Stock A Sign That The Market Could be Wrong Given Its...
Simply Wall St. via Yahoo Finance· 1 year agoWith its stock down 11% over the past three months, it is easy to disregard BioNTech (NASDAQ:BNTX)....
BioNTech Stock Surges On Surprise Profit, Strong Sales. But Report Has Downside.
Investor's Business Daily· 6 months agoCovid vaccine maker BioNTech reported a surprise profit and better-than-expected September-quarter...
BioNTech SE (NASDAQ:BNTX) stock most popular amongst private equity firms who own 44%, while...
Simply Wall St. via Yahoo Finance· 1 year agoA look at the shareholders of BioNTech SE (NASDAQ:BNTX) can tell us which group is most powerful....
We Ran A Stock Scan For Earnings Growth And BioNTech (NASDAQ:BNTX) Passed With Ease
Simply Wall St. via Yahoo Finance· 1 year agoFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a...
BioNTech Trims Expenses As Plummeting Covid Vaccine Sales Still Lag Expectations
Investor's Business Daily· 9 months agoGerman biotech BioNTech said Monday it's trimming drug development costs amid plummeting Covid...